Background illustration for clinical trials search

Stem Cells Clinical Trials

Find clinical trials for stem cells. Search for stem cells clinical trials in different cities and states across the United States.

Filter

Quantitative Assessment of Autologous Fat Transfer

for
Autologous Fat Grafting
Location: Chicago IL, Houston TX
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT06343831

Recruiting

Brain MRF in Children, Adolescents and Young Adults With Acute Leukemia

for
Acute Leukemia, Acute Lymphoblastic Leukemia, Pediatric,
Location: Cleveland OH
Sponsor: Case Comprehensive Cancer Center

Sex: All

Age: 0 - 30

Code: NCT06421155

Recruiting

Addressing Cancer Care Equity With Social Determinants of Health Screening and Early Intervention

for
Leukemia, Acute
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT07671209

Recruiting

Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms

for
Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT07094750

Recruiting

Subcutaneous Blinatumomab for Treatment of Adult Patients With CD19-Positive Mixed Phenotype Acute Leukemia (MPAL)

for
CD19 Positive, Mixed Phenotype Acute Leukemia (MPAL)
Location: Morgantown WV
Sponsor: West Virginia University

Sex: All

Age: 18+

Code: NCT07222579

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Revumenib and Mezigdomide in People With Leukemia

for
Leukemia, Acute Leukemia, Relapse Leukemia, Refractory Leukemia,
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 12+

Code: NCT07356154

Phase 1, Phase 2, Recruiting

Assessing Pulmonary Changes in HSCT

for
HSCT, Respiratory, Gas Exchange Impairment
Location: Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 3+

Code: NCT07823036

Phase 1, Phase 2, Recruiting

TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT

for
GVHD, Hematopoietic Cell Transplantation (HCT),
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 18 - 70+

Code: NCT07302776

Phase 1, Recruiting

Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant

for
GVHD,Acute, Acute Leukemia, Myelodysplastic Syndromes,
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 18 - 60

Code: NCT06315309

Phase 2, Recruiting

The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias

for
Relapsed or Resistant Acute Leukaemias
Location: Baltimore MD, Chapel Hill NC, Tampa FL, Fairway KS
Sponsor: Lin BioScience, Inc

Sex: All

Age: 18 - 70+

Code: NCT05756322

Phase 1, Phase 2, Recruiting

MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases

for
AML, MDS, Acute Leukemia, Acute Myeloid Leukemia,
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 2 - 70+

Code: NCT07493538

Phase 2, Recruiting

HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

for
Juvenile Myelomonocytic Leukemia,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 0 - 70+

Code: NCT03326921

Phase 1, Recruiting

Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer

for
Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT07046078

Phase 2, Recruiting

Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse

for
Acute Myeloid Leukemia, Acute Undifferentiated Leukemia,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT06928662

Phase 1, Phase 2, Recruiting

CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma

for
Relapsed Pediatric ALL, Hematopoietic Cell Transplantation,
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 0 - 21

Code: NCT07257419

Phase 1, Recruiting

Prospective Evaluation of Disparities in Provision of Allogeneic Transplantation

for
Allogeneic Transplantation
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06450353

Recruiting

BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI)

for
Acute Leukemia, MDS
Location: Chicago IL
Sponsor: University of Illinois at Chicago

Sex: All

Age: 18 - 70+

Code: NCT04187105

Phase 2, Recruiting

Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing

for
Acute Leukemia, Leukemia
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT06907797

Recruiting

APOLLO: Personalized rehAbilitation PrOgram in aLLOgeneic Bone Marrow Transplantation

for
Allogeneic Disease
Location: Edmonton
Sponsor: University of Alberta

Sex: All

Age: 18 - 70

Code: NCT05579678

Recruiting

Standard-of-Care Reduced-Intensity Conditioning (RIC) With 200 Versus 400 cGy of Total Body Irradiation (TBI) in Patients With Acute Leukemia Undergoing First Allogeneic Blood or Marrow Transplantation (BMT)

for
Acute Leukemia, Acute Lymphoblastic Lymphoma
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 0+

Code: NCT06803745

Recruiting

What stem cell therapy clinical trials are studying now

Transplants for blood cancers and blood disorders. Hematopoietic stem cell transplant replaces a person's blood forming system with their own stored cells or a donor's. Trials test safer conditioning, better donor matching, including half matched family donors for sickle cell disease, and ways to prevent graft versus host disease.

Transplants for autoimmune disease. Resetting the immune system with a person's own stem cells is being tested against the best available drugs in relapsing multiple sclerosis, in a Phase 3 trial funded by the National Institutes of Health at more than 20 US sites.

Mesenchymal stromal cells. Cells from bone marrow or fat that calm inflammation, tested for Crohn's disease, graft versus host disease, and hard to heal wounds. The first one was approved in 2024 after decades of trials.

Cells made from stem cells. Lab grown dopamine neurons for Parkinson's disease and insulin producing islet cells for type 1 diabetes, both now in or entering late stage trials.

Gene corrected stem cells. A person's own blood stem cells are edited to fix a mutation and returned. Two such therapies for sickle cell disease were approved in 2023; see gene therapy clinical trials. Immune cell therapies such as CAR T are a different technology, covered on our CAR T cell therapy page.

Stem cell transplants are part of care for leukemia, lymphoma, and multiple myeloma; each page lists its own studies.

Article preview image

New to research? Read how informed consent works.

Informed Consent in Clinical Trials: What Is It and How It’s Obtained

Who can participate in stem cell therapy clinical trials?

Is stem cell therapy safe?

How long does stem cell therapy last?

Do stem cell trial participants get paid?

How to enroll in a stem cell clinical trial